UIH(SH:688271) Sou Hu Cai Jing·2025-10-27 12:05Core Viewpoint - The stock of United Imaging Healthcare (688271) has shown a positive trend with a closing price of 143.83 yuan, reflecting a 1.17% increase on October 27, 2025, amidst varying capital flows from different investor categories [1] Financial Performance - For the first half of 2025, United Imaging Healthcare reported a main revenue of 6.016 billion yuan, a year-on-year increase of 12.79% - The net profit attributable to shareholders was 998 million yuan, up 5.03% year-on-year - The net profit after deducting non-recurring gains and losses was 966 million yuan, increasing by 21.01% year-on-year - In Q2 2025, the company achieved a single-quarter main revenue of 3.538 billion yuan, a year-on-year increase of 18.6% - The single-quarter net profit attributable to shareholders was 628 million yuan, up 6.99% year-on-year - The single-quarter net profit after deducting non-recurring gains and losses was 587 million yuan, increasing by 17.96% year-on-year - The company reported a debt ratio of 27.52% and investment income of 39.84 million yuan, with financial expenses of -49.62 million yuan and a gross profit margin of 47.93% [3] Market Position - United Imaging Healthcare has a total market value of 118.539 billion yuan, ranking 2nd in the medical device industry - The company's net assets stand at 20.787 billion yuan, ranking 3rd in the industry - The net profit of 998 million yuan places it 4th in the industry - The price-to-earnings ratio (dynamic) is 59.39, which is lower than the industry average of 66.17, ranking 61st - The price-to-book ratio is 5.72, significantly higher than the industry average of 3.77, ranking 105th - The gross profit margin of 47.93% is below the industry average of 51.35%, ranking 73rd - The net profit margin of 16.42% is above the industry average of 10.27%, ranking 44th - The return on equity (ROE) is 4.9%, outperforming the industry average of 2.37%, ranking 41st [3] Investor Sentiment - In the last 90 days, 24 institutions have rated the stock, with 19 buy ratings and 5 hold ratings - The average target price set by institutions over the past 90 days is 171.35 yuan [4]